Feature | July 15, 2011| Adhir Shroff, M.D., MPH

Straight From the Wrist...

A review of recent transradial study data

Impact of Transradial and Transfemoral Coronary Interventions on Bleeding and Net Adverse Clinical Events in Acute Coronary Syndromes
Martial Hamon, et al     EuroIntervention 2011, 7:91-97

Study design   

• Post-hoc analysis of the OASIS 5 trial for patients undergoing an early invasive strategy.
• Patients received enoxaparin or fondaparinux.
• 7,885 patients underwent PCI using either femoral or radial access included in the analysis

Primary endpoint: Composite ischemia and major bleeding endpoints at 9 days, 30 days and 6 months; Net adverse clinical events defined as combination of ischemic endpoints and major bleeding

Result: No difference in ischemic endpoints based on approach; Radial approach associated with significantly less bleeding with either anticoagulation strategy
 

Bottom line: Radial approach limits bleeding without impacting ischemic outcomes


Reduction of Scatter Radiation During Transradial Percutaneous Coronary Angiography: A Randomized Trial Using a Lead-free Radiation Shield
Luigi Politi, et al    Catheterization and Cardiovascular Interventions (Epub ahead of print)

Study design: Prospective, randomized study of a lead-free radiation shield
Primary endpoint: Radiation exposure to the operator during diagnostic cardiac catheterization; Exposure measured at chest, left eye, left wrist and thyroid

Results: Despite similar fluoroscopy times and total radiation dose, radiation exposure decreased by 23% relative to control;  Radiation exposure was lower at all measured points


Bottom line: Use of a radiation drape can dramatically decrease radiation exposure to the operator

 


A Single Center Experience With Same-Day Transradial-PCI Patients: A Contrast With Published Guidelines
Ian C. Gilchrist, et al    Catheterization and Cardiovascular Interventions (Epub ahead of print)

Study design: Retrospective review of 100 sequential patients who underwent same day discharge following TR-PCI

Primary endpoint: Adherence to SCAI/ACC appropriateness criteria for outpatient PCI

Results: Only 15% of patients met appropriateness criteria; The most common contraindications to discharge from the Consensus statement included advanced age (n=26), insulin dependent DM (n=5), contrast allergies (n=4), presence of COPD (n=8) and multivessel CAD (n=4); No patients were readmitted or experienced a post-PCI complication


Bottom line: Use of the transradial approach with a structured follow-up process can lead to a successful same day discharge program
 

Related Content

Radial access in the U.S. is now approaching 50 percent. Tranradial access also shows benefit for mortality and decreases in acute kidney injury (AKI).
Feature | Radial Access | February 14, 2020 | Dave Fornell, Editor
Transradial access for percutaneous coronary intervention (PCI) in the United States has grown rapidly over the past
News | Radial Access | December 30, 2019
December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of propri
The three sites most often used for distal radial artery access are the (1) anatomic snuffbox above the scaphoid (left), (2) adjacent to the snuffbox at the trapezium bone (center), and (3) the first intermetacarpal space (right). The author’s preference is either of the first two options, although good outcomes have been reported with use of the intermetacarpal space.

The three sites most often used for distal radial artery access are the (1) anatomic snuffbox above the scaphoid (left), (2) adjacent to the snuffbox at the trapezium bone (center), and (3) the first intermetacarpal space (right). The author’s preference is either of the first two options, although good outcomes have been reported with use of the intermetacarpal space.

Feature | Radial Access | November 21, 2019 | Enrique Flores, M.D., RPVI
Interest in distal radial artery access (DRA) is growing rapidly.
Videos | Radial Access | October 22, 2019
Sunil Rao, M.D., chief of cardiology, Durham VA Health System and a professor at Duke University, and Prashant Kaul, M....
Cordis Announces U.S. Launch of Radial 360 Portfolio
Technology | Radial Access | May 15, 2019
Cordis, a Cardinal Health company, recently announced the full U.S. launch of its Radial 360 portfolio, offering a...
Ferdinand Kiemeneij, M.D., explains the history of the transradial access during an interview with DAIC at TCT 2017.

Ferdinand Kiemeneij, M.D., explains the history of the transradial access during an interview with DAIC at TCT 2017.

Feature | Radial Access | February 22, 2018 | Dave Fornell
Interventional cardiology has witnessed a rapid and constant evolution in both techniques and device technology since
Videos | Radial Access | February 16, 2018
The father of transradial artery access,...
SCAI Launches TRAnsition for VALUE Radial Access Educational Initiative
News | Radial Access | November 13, 2017
The Society for Cardiovascular Angiography and Interventions recently announced the launch of TRAnsition for VALUE, a...